Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection (Q34678105)

3 August 2017

title

Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection (English)

1 reference

3 August 2017

8

Dietmar Fuchs

1 reference

3 August 2017

9

Richard W Price

1 reference

3 August 2017

7

Lars Hagberg

1 reference

3 August 2017

11

Serena Spudich

1 reference

3 August 2017

3

Julia Peterson

1 reference

3 August 2017

4

Evelyn Lee

1 reference

3 August 2017

10

Magnus Gisslen

1 reference

3 August 2017

Joome Suh

1

1 reference

3 August 2017

Elizabeth Sinclair

series ordinal

2

1 reference

3 August 2017

Tassos C Kyriakides

series ordinal

5

1 reference

3 August 2017

Fang-Yong Li

series ordinal

6

1 reference

3 August 2017

publication date

3 December 2014

1 reference

Journal of Neuroinflammation

3 August 2017

published in

1 reference

3 August 2017

volume

11

1 reference

3 August 2017

page(s)

199

1 reference

Creative Commons Attribution 4.0 International

3 August 2017

copyright license

start time

1 December 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Restrictions to HIV-1 replication in resting CD4 T lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Central nervous system viral invasion and inflammation during acute HIV infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Raltegravir treatment intensification does not alter cerebrospinal fluid HIV-1 infection or immunoactivation in subjects on suppressive therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Antiretroviral treatment effect on immune activation reduces cerebrospinal fluid HIV-1 infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Biomarkers of HIV-1 CNS infection and injury

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Diagnosis and management of acute HIV infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

The neuropathogenesis of AIDS

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

The impact of HIV-associated neuropsychological impairment on everyday functioning

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Medication adherence among HIV adults: effects of cognitive dysfunction and regimen complexity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Antiretroviral treatment of central nervous system HIV-1 infection: a review

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Increased replication of T-cell-tropic HIV strains and CXC-chemokine receptor-4 induction in T cells treated with macrophage inflammatory protein (MIP)-1α, MIP-1β and RANTES β-chemokines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Markers of immune stimulation in the cerebrospinal fluid during HIV infection: a longitudinal study.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Early penetration of the blood-brain-barrier by HIV.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Expansion of neopterin and beta 2-microglobulin in cerebrospinal fluid reaches maximum levels early and late in the course of human immunodeficiency virus infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors

7 July 2018

1 reference

https://api.crossref.org/works/10.1186/S12974-014-0199-Y

Variable benefit in neuropsychological function in HIV-infected HAART-treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12974-014-0199-Y

Immune activation of the central nervous system is still present after >4 years of effective highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12974-014-0199-Y

Highly activated CD8( ) T cells in the brain correlate with early central nervous system dysfunction in simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12974-014-0199-Y

CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12974-014-0199-Y

Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12974-014-0199-Y

T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1186/S12974-014-0199-Y

Elevated levels of CD38 CD8 T cells in HIV infection add to the prognostic value of low CD4 T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4263211

Immune activation set point during early HIV infection predicts subsequent CD4 T-cell changes independent of viral load

26 October 2018

1 reference

https://api.crossref.org/works/10.1186/S12974-014-0199-Y

Cerebrospinal fluid viral load in HIV-1-infected patients without antiretroviral treatment: a longitudinal study

21 January 2018

1 reference

12 December 2020

Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group

1 reference

12 December 2020

Determination of neopterin in serum and urine

1 reference

12 December 2020

Diagnosis of primary HIV-1 infection and duration of follow-up after HIV exposure. Karolinska Institute Primary HIV Infection Study Group

1 reference

12 December 2020

10.1186/S12974-014-0199-Y

Identifiers

DOI

1 reference

Dimensions Publication ID

3 August 2017

0 references

1 reference

3 August 2017

1 reference